A Controlled Study on Pain Management With Injection of Botulinum Toxin for Glabellar Line Correction
Clinical trial NCT06161246 · COMPLETED
Trial details
- NCT number
- NCT06161246
- Sponsor
- Galderma R&D
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-23
- Primary completion
- 2024-02-15
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.